Translational and clinical immunology
Defects in lymphocyte telomere homeostasis contribute to cellular immune phenotype in patients with cartilage-hair hypoplasia

https://doi.org/10.1016/j.jaci.2016.11.051Get rights and content

Background

Mutations in the long noncoding RNA RNase component of the mitochondrial RNA processing endoribonuclease (RMRP) give rise to the autosomal recessive condition cartilage-hair hypoplasia (CHH). The CHH disease phenotype has some overlap with dyskeratosis congenita, a well-known “telomere disorder.” RMRP binds the telomerase reverse transcriptase (catalytic subunit) in some cell lines, raising the possibility that RMRP might play a role in telomere biology.

Objective

We sought to determine whether a telomere phenotype is present in immune cells from patients with CHH and explore mechanisms underlying these observations.

Methods

We assessed proliferative capacity and telomere length using flow–fluorescence in situ hybridization (in situ hybridization and flow cytometry) of primary lymphocytes from patients with CHH, carrier relatives, and control subjects. The role of telomerase holoenzyme components in gene expression and activity were assessed by using quantitative PCR and the telomere repeat amplification protocol from PBMCs and enriched lymphocyte cultures.

Results

Lymphocyte cultures from patients with CHH display growth defects in vitro, which is consistent with an immune deficiency cellular phenotype. Here we show that telomere length and telomerase activity are impaired in primary lymphocyte subsets from patients with CHH. Notably, telomerase activity is affected in a gene dose-dependent manner when comparing heterozygote RMRP carriers with patients with CHH. Telomerase deficiency in patients with CHH is not mediated by abnormal telomerase gene transcript levels relative to those of endogenous genes.

Conclusion

These findings suggest that telomere deficiency is implicated in the CHH disease phenotype through an as yet unidentified mechanism.

Section snippets

Ethical statement and patients' characteristics

All samples from patients with CHH and their relatives were obtained with informed consent and approval of local ethical review boards in accordance with the Declaration of Helsinki. The patients were cared for at the Clinic for Special Children in Strasburg, Pennsylvania. Clinical and molecular studies were performed with oversight from the Lancaster General Hospital Institutional Review Board. All reported subjects underwent laboratory and molecular testing, as previously described.14 The

Results

Thymic and T-lymphocyte functions from 5 of the 15 patients with CHH (UPN2, UPN3, and UPN6-UPN8) have been previously reported and demonstrated reduced thymic output, reduced or delayed cell-cycle progression, and a moderate increase in apoptosis19 compared with healthy subjects. All subjects studied in this report were heterozygous carriers or homozygous for lncRNA RMRP n.70 A>G (see the diagram of RMRP folding prediction in Fig 120).

Discussion

Patients with CHH display some clinical features that overlap with telomere biology disorders and are particularly susceptible to immune deficiency. Interestingly, both disorders are categorized as diseases with a significant risk of bone marrow failure and have been considered to belong to disease groups, including bone marrow failure syndromes, primary immunodeficiencies,25 and ribosomopathies.26

Model studies of CHH have been challenging thus far because of the essential functions of lncRNA

References (38)

  • A. Narla et al.

    Ribosomopathies: human disorders of ribosome dysfunction

    Blood

    (2010)
  • G. Aubert et al.

    Telomere length measurement—caveats and a critical assessment of the available technologies and tools

    Mutat Res

    (2012)
  • M. Knudson et al.

    Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita

    Blood

    (2005)
  • V. Bordon et al.

    Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation

    Blood

    (2010)
  • S.M. Gadalla et al.

    Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita

    Biol Blood Marrow Transplant

    (2013)
  • T. Sulisalo et al.

    Cartilage-hair hypoplasia gene assigned to chromosome 9 by linkage analysis

    Nat Genet

    (1993)
  • M. Taskinen et al.

    Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma

    Am J Med Genet A

    (2008)
  • Y. Maida et al.

    An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA

    Nature

    (2009)
  • S. Mukherjee et al.

    Separation of telomerase functions by reverse genetics

    Proc Natl Acad Sci U S A

    (2011)
  • Cited by (0)

    Work in the Lansdorp laboratory is supported by grants from the Canadian Institutes of Health Research (MOP38075 and GMH79042). N.L.R. worked at the Clinic for Special Children, Strasburg, Pennsylvania, during the majority of this work.

    Disclosure of potential conflict of interest: G. Aubert is employed by Repeat Diagnostics. P. M. Lansdorp is employed by Canadian Institutes of Health Research (MOP38075 and GMH79042) and has received stock options from Repeat Diagnostics. N. L. Rider is employed by Baylor College of Medicine and receives royalties from UpToDate. K. A. Strauss declares that he has no relevant conflicts of interest.

    View full text